Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Health Finance and Policy

SIXTIETH MEETING

2021-2022 Regular Session - Friday, March 18, 2022

STATE OF MINNESOTA SIXTIETH MEETING
HOUSE OF REPRESENTATIVES NINETY-SECOND SESSION

HEALTH FINANCE AND POLICY COMMITTEE

MINUTES

Representative Tina Liebling, Chair of the Committee, called the virtual Health Finance and Policy Committee meeting to order at 10:30 A.M. on March 18, 2022 pursuant to House rule 10.01. The meeting is being broadcast via Zoom and House Public Information Services.

The Committee Legislative Assistant noted the roll.

Members present:
LIEBLING, Tina, Chair
HUOT, John, Vice Chair
SCHOMACKER, Joe, Minority Lead
AKLAND, Susan
BACKER, Jeff
BAHNER, Kristin
BIERMAN, Robert
BOLDON, Liz
DEMUTH, Lisa
FREIBERG, Mike
GRUENHAGEN, Glenn
KIEL, Debra
MORRISION, Kelly
MUNSON, Jeremy
PRYOR, Laurie
QUAM, Duane
REYER, Liz
SCHULTZ, Jennifer
WOLGAMOTT, Dan

Members excused:

A quorum was present.

Representative Huot moved that the minutes of March 16, 2022 be approved. THE MOTION PREVAILED.

H. F. 4265, (Olson) Opioid settlement proceed deposit and allocation provided, two accounts established in the opiate epidemic response fund, separate opioid account in the state treasury eliminated, time frame modified for eliminating the opioid manufacturer registration fee and reducing license fees, and municipal claims barred against litigants in settled opioid cases.

Chair Liebling moved that HF4265 be recommended to pass and re-referred to the Committee on Judiciary Finance and Civil Law.

Representative Olson and Representative Baker presented their bill.

Testifying:
1. Evan Romanoff, Assistant Attorney General, Office of Minnesota Attorney General
2. Angie Thies, Child Wellbeing Policy Analyst, Association of Minnesota Counties

Chair Liebling renewed her motion that HF4265 be recommended to pass and re-referred to the Committee on Judiciary Finance and Civil Law.

Chair Liebling stated there would be a roll call vote. The results were as follows:

AYE
LIEBLING, Tina
HUOT, John
SCHOMACKER, Joe
AKLAND, Susan
BACKER, Jeff
BAHNER, Kristin
BIERMAN, Robert
BOLDON, Liz
DEMUTH, Lisa
FREIBERG, Mike
GRUENHAGEN, Glenn
KIEL, Debra
MORRISON, Kelly
MUNSON, Jeremy
PRYOR, Laurie
QUAM, Duane
REYER, Liz
SCHULTZ, Jennifer
WOLGAMOTT, Dan

NAY

On a vote of 19 AYES and 0 NAYS THE MOTION PREVAILED.

HF3972 (Richardson) Nondiscrimination and equity required in access to organ transplants, and penalties prescribed.

Chair Liebling moved that HF3972, First Engrossment, be recommended to pass and be placed on the General Register

Representative Richardson presented her bill.

Chair Liebling renewed her motion that HF3972, First Engrossment, be recommended to pass and be placed on the General Register.

Chair Liebling stated there would be a roll call vote. The results were as follows:

AYE
LIEBLING, Tina
HUOT, John
SCHOMACKER, Joe
AKLAND, Susan
BACKER, Jeff
BAHNER, Kristin
BIERMAN, Robert
BOLDON, Liz
DEMUTH, Lisa
FREIBERG, Mike
GRUENHAGEN, Glenn
KIEL, Debra
MORRISON, Kelly
MUNSON, Jeremy
PRYOR, Laurie
QUAM, Duane
REYER, Liz
SCHULTZ, Jennifer
WOLGAMOTT, Dan

On a vote of 19 AYES and 0 NAYS THE MOTION PREVAILED.

HF3958 (Morrison) Seizure detection device medical assistance coverage
required.

Representative Morrison moved that HF3958 be laid over for possible inclusion in the Health Finance and Policy Committee bill.

Representative Morrison presented her bill.

Testifying:
1. April Mountjoy, Volunteer, Epilepsy Foundation of Minnesota

Chair Liebling laid over HF3958 for possible inclusion in the Committee bill.

HF4157 (Pryor) Medical assistance and MinnesotaCare enrollee disenrollment procedures specified, and 12-month continuous medical assistance eligibility provided.

Representative Pryor moved that HF4157 be laid over for possible inclusion in the Health Finance and Policy Committee bill.

Representative Pryor moved the H4157A2 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Pryor presented her bill as amended.

Testifying:
1. Anne Quincy, Supervising Attorney, Mid-Minnesota Legal Aid

Chair Liebling laid over HF4157, as amended, for possible inclusion in the Committee bill.

HF3360 (Morrison) Commissioner of health required to study issues of statewide register development for provider orders for life-sustaining treatment, and report required.

Representative Morrison moved that HF3360 be laid over for possible inclusion in the Health Finance and Policy Committee bill.

Representative Morrison presented her bill.

Testifying:
1. Dr. Randy Rice, President, Minnesota Medical Association

Chair Liebling laid over HF3360 for possible inclusion in the Committee bill.

HF4062 (Reyer) Hospice respite and end-of-life care medical assistance benefit for individual under age of 22 established.

Representative Reyer moved that HF4062 be laid over for possible inclusion in the Health Finance and Policy Committee bill.

Representative Reyer moved the H4062A1 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Reyer presented her bill as amended.

Testifying:
1. Katie Lindenfelser, Founder and Executive Director, Crescent Cove
2. Kathryn Williams, Family Member of Patient

Ann Bobst, Director of Legislative and External Affairs, Health Care Administration, Minnesota Department of Human Services, responded to member questions.

Chair Liebling laid over HF4062, as amended, for possible inclusion in the Committee bill.

HF3924 (Lippert) Board of Pharmacy required to provide central repository under contract to administer medication repository program with any legislative funding, and over-the-counter medication donation conforming changes made.

Chair Liebling moved that HF3924 be laid over for possible inclusion in the Health Finance and Policy Committee bill.

Representative Lippert presented his bill.

Testifying:
1. Dr. Rowan Mahon, Founder, Minnesota Medication Repository Program

Chair Liebling laid over HF3924 for possible inclusion in the Committee bill.

HF3595 (Edelson) Cannabinoid product regulation provided, sale of cannabinoid containing products limited to individuals 21 years of age or older, cannabinoid product labeling required to contain a barcode or matrix barcode, and cannabinoid containing products that meet regulation requirements established as not controlled substances.

Chair Liebling moved that HF3595 be recommended to pass and re-referred to the Committee on Commerce Finance and Policy.

Chair Liebling moved the H3595DE3 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Edelson presented her bill as amended.

Testifying:
1. Dr. Cody Wiberg, Executive Director, Minnesota Board of Pharmacy
2. Maren Schroeder, Policy Director, Sensible Change Minnesota
3. Steven Brown, Board Member, Minnesota Cannabis Association
4. Craig Sutherland, Owner, Sutherland CBD

Chair Liebling renewed her motion that HF3595, as amended, be recommended to pass and re-referred to the Committee on Commerce Finance and Policy.

Chair Liebling stated there would be a roll call vote. The results were as follows:

AYE
LIEBLING, Tina
HUOT, John
SCHOMACKER, Joe
AKLAND, Susan
BACKER, Jeff
BIERMAN, Robert
BOLDON, Liz
FREIBERG, Mike
MORRISON, Kelly
PRYOR, Laurie
QUAM, Duane
REYER, Liz
SCHULTZ, Jennifer
WOLGAMOTT, Dan

NAY
DEMUTH, Lisa
KIEL, Debra
MUNSON, Jeremy

EXCUSED
BAHNER, Kristin
GRUENHAGEN, Glenn

On a vote of 14 AYES and 3 NAYS THE MOTION PREVAILED.

The meeting was adjourned at 12:18 P.M.




________________________________________________________
Representative Tina Liebling, Chair




________________________________________________________
Krysta Niedernhöfer, Committee Legislative Assistant
More Info On This Meeting..
Bills Added:
  • HF3360 (Morrison) - Commissioner of health required to study issues of statewide register development for provider orders for life-sustaining treatment, and report required.
  • HF3595 (Edelson) - Cannabinoid product regulation provided, sale of cannabinoid containing products limited to individuals 21 years of age or older, cannabinoid product labeling required to contain a barcode or matrix barcode, additional requirements provided for edible cannabinoid products, food definition modified, and cannabinoid containing products that meet regulation requirements established as not controlled substances.
  • HF3924 (Lippert) - Board of Pharmacy required to provide central repository under contract to administer medication repository program with any legislative funding, and over-the-counter medication donation conforming changes made.
  • HF3958 (Morrison) - Seizure detection device medical assistance coverage required.
  • HF3972 (Richardson) - Race and ethnicity added to nondiscrimination in access to transplants.
  • HF4062 (Reyer) - Hospice respite and end-of-life care medical assistance benefit for individual under age of 22 established.
  • HF4157 (Pryor) - Medical assistance and MinnesotaCare enrollee disenrollment procedures specified, and 12-month continuous medical assistance eligibility provided.
  • HF4265 (Olson) - Opioid settlement proceed deposit and allocation provided, two accounts established in the opiate epidemic response fund, separate opioid account in the state treasury eliminated, time frame modified for eliminating the opioid manufacturer registration fee and reducing license fees, and municipal claims barred against litigants in settled opioid cases.
House TV Video:
View Archive

02:39 - HF4265 (Olson, L.) Opioid settlement proceed deposit and allocation provided, two accounts established in the opiate epidemic response fund, separate opioid account in the state treasury eliminated, time frame modified for eliminating the opioid manufacturer registration fee and reducing license fees, and municipal claims barred against litigants in settled opioid cases.
26:09 - HF3972 (Richardson) Nondiscrimination and equity required in access to organ transplants, and penalties prescribed.
41:57 - HF3958 (Morrison) Seizure detection device medical assistance coverage required.
48:06 - HF4157 (Pryor) Medical Assistance and MinnesotaCare enrollee disenrollment procedures specified, and 12-month continuous medical assistance eligibility provided.
56:31 - HF3360 (Morrison) Commissioner of health required to study issues of statewide register development for provider orders for life-sustaining treatment, and report required.
1:06:21 - HF4062 (Reyer) Hospice respite and end-of-life care medical assistance benefit for individual under age of 22 established.
1:15:53 - HF3924 (Lippert) Board of Pharmacy required to provide central repository under contract to administer medication repository program with any legislative funding, and over-the-counter medication donation conforming changes made.
1:26:43 - HF3595 (Edelson) Cannabinoid product regulation provided, sale of cannabinoid containing products limited to individuals 21 years of age or older, cannabinoid product labeling required to contain a barcode or matrix barcode, and cannabinoid containing products that meet regulation requirements established as not controlled substances.
Runs 1 hour, 50 minutes.


H. F. 4265, (Olson) Opioid settlement proceed deposit and allocation provided, two accounts established in the opiate epidemic response fund, separate opioid account in the state treasury eliminated, time frame modified for eliminating the opioid manufacturer registration fee and reducing license fees, and municipal claims barred against litigants in settled opioid cases.
HF3972 (Richardson) Nondiscrimination and equity required in access to organ transplants, and penalties prescribed. (Pending re-referral)
HF3958 (Morrison) Seizure detection device medical assistance coverage required.
HF4157 (Pryor) Medical assistance and MinnesotaCare enrollee disenrollment procedures specified, and 12-month continuous medical assistance eligibility provided.
HF3360 (Morrison) Commissioner of health required to study issues of statewide register development for provider orders for life-sustaining treatment, and report required.
HF4062 (Reyer) Hospice respite and end-of-life care medical assistance benefit for individual under age of 22 established.
HF3924 (Lippert) Board of Pharmacy required to provide central repository under contract to administer medication repository program with any legislative funding, and over-the-counter medication donation conforming changes made.
HF3595 (Edelson) Cannabinoid product regulation provided, sale of cannabinoid containing products limited to individuals 21 years of age or older, cannabinoid product labeling required to contain a barcode or matrix barcode, and cannabinoid containing products that meet regulation requirements established as not controlled substances.

Amendment and testifier/material deadline will be 10:30 AM on Thursday, March 17th. Items may be added or deleted.

This meeting will be held in accordance with House Rule 10.01, which may be viewed here: https://www.house.leg.state.mn.us/comm/docs/HmNgjtZ_KkKBF3cKO2DXmw.pdf

Public Viewing Information:
This remote hearing will be live-streamed via the House webcast schedule page: https://www.house.leg.state.mn.us/htv/schedule.asp All events are closed-captioned. Other reasonable accessibility accommodations may be made with advance notice.

Meeting documents will be posted on the House Health Finance and Policy Committee website at https://www.house.leg.state.mn.us/Committees/Home/92011.

To provide feedback on digital accessibility of meeting information, please submit comments through the Minnesota Legislature Accessibility & Usability Comment Form. If you require an accommodation, please contact John Howe at: John.Howe@house.mn or by leaving a message at 651-296-3208. Please contact Health Committee Administrator, Patrick.McQuillan@house.mn with questions on the meeting agenda. To learn more about requesting an accommodation, please visit the FAQs for Disability Access.